Amanita muscaria extract potentiates production of proinflammatory cytokines by dsRNA-activated human microglia
Recent interest in mushrooms and their components as potential therapies for mental health, along with recent government and health authority approvals, has necessitated a more comprehensive understanding of their effects on the cellular microenvironment of the brain. Amanita muscaria has been inges...
Saved in:
| Published in | Frontiers in pharmacology Vol. 14; p. 1102465 |
|---|---|
| Main Authors | , , , |
| Format | Journal Article |
| Language | English |
| Published |
Switzerland
Frontiers Media
12.04.2023
Frontiers Media S.A |
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Recent interest in mushrooms and their components as potential therapies for mental health, along with recent government and health authority approvals, has necessitated a more comprehensive understanding of their effects on the cellular microenvironment of the brain. Amanita muscaria has been ingested as a treatment for a variety of ailments for centuries, most notably those affecting the central nervous system and conditions associated with neuroinflammation. However, the effects of these extracts on neuroinflammatory cells, such as microglia, are unknown. The effect of commercially-sourced A. muscaria extract (AME-1) on human microglial cell line (HMC3) expression of surface receptors such as CD86, CXCR4, CD45, CD125 and TLR4 was determined by flow cytometry. AME-1 upregulated expression of all of these receptors. The effect of AME-1 on HMC3 production of IL-8 and IL-6 was determined and compared to tumor necrosis factor (TNF), polyinosinic-polycytidylic acid [poly(I:C)], substance P and lipopolysaccharide (LPS), all known activators of HMC-3 and primary microglia. HMC3 produced both IL-8 and IL-6 when activated with LPS, TNF and poly(I:C) but not when they were activated with substance P. Although AME-1 at higher concentrations increased IL-8 production of HMC3 on its own, AME-1 notably potentiated HMC3 production of IL-8 in response to poly(I:C). AME-1 altered expression of toll-like receptor 3 (TLR3) mRNA but not surface protein by HMC3. AME-1 also did not significantly alter expression of retinoic acid-inducible gene I (RIG-I) or melanoma differentiation-associated protein 5 (MDA5), both cytosolic sensors of dsRNA. Metabolomics analysis showed that AME-1 contained several metabolites, including the autophagy inducer, trehalose. Like AME-1, trehalose also potentiated HMC3 poly(I:C) mediated production of IL-8. This study suggests that A. muscaria extracts can modify HMC3 inflammatory responses, possibly due to their trehalose content. NRC publication: Yes |
|---|---|
| AbstractList | Recent interest in mushrooms and their components as potential therapies for mental health, along with recent government and health authority approvals, has necessitated a more comprehensive understanding of their effects on the cellular microenvironment of the brain. Amanita muscaria has been ingested as a treatment for a variety of ailments for centuries, most notably those affecting the central nervous system and conditions associated with neuroinflammation. However, the effects of these extracts on neuroinflammatory cells, such as microglia, are unknown. The effect of commercially-sourced A. muscaria extract (AME-1) on human microglial cell line (HMC3) expression of surface receptors such as CD86, CXCR4, CD45, CD125 and TLR4 was determined by flow cytometry. AME-1 upregulated expression of all of these receptors. The effect of AME-1 on HMC3 production of IL-8 and IL-6 was determined and compared to tumor necrosis factor (TNF), polyinosinic-polycytidylic acid [poly(I:C)], substance P and lipopolysaccharide (LPS), all known activators of HMC-3 and primary microglia. HMC3 produced both IL-8 and IL-6 when activated with LPS, TNF and poly(I:C) but not when they were activated with substance P. Although AME-1 at higher concentrations increased IL-8 production of HMC3 on its own, AME-1 notably potentiated HMC3 production of IL-8 in response to poly(I:C). AME-1 altered expression of toll-like receptor 3 (TLR3) mRNA but not surface protein by HMC3. AME-1 also did not significantly alter expression of retinoic acid-inducible gene I (RIG-I) or melanoma differentiation-associated protein 5 (MDA5), both cytosolic sensors of dsRNA. Metabolomics analysis showed that AME-1 contained several metabolites, including the autophagy inducer, trehalose. Like AME-1, trehalose also potentiated HMC3 poly(I:C) mediated production of IL-8. This study suggests that A. muscaria extracts can modify HMC3 inflammatory responses, possibly due to their trehalose content.Recent interest in mushrooms and their components as potential therapies for mental health, along with recent government and health authority approvals, has necessitated a more comprehensive understanding of their effects on the cellular microenvironment of the brain. Amanita muscaria has been ingested as a treatment for a variety of ailments for centuries, most notably those affecting the central nervous system and conditions associated with neuroinflammation. However, the effects of these extracts on neuroinflammatory cells, such as microglia, are unknown. The effect of commercially-sourced A. muscaria extract (AME-1) on human microglial cell line (HMC3) expression of surface receptors such as CD86, CXCR4, CD45, CD125 and TLR4 was determined by flow cytometry. AME-1 upregulated expression of all of these receptors. The effect of AME-1 on HMC3 production of IL-8 and IL-6 was determined and compared to tumor necrosis factor (TNF), polyinosinic-polycytidylic acid [poly(I:C)], substance P and lipopolysaccharide (LPS), all known activators of HMC-3 and primary microglia. HMC3 produced both IL-8 and IL-6 when activated with LPS, TNF and poly(I:C) but not when they were activated with substance P. Although AME-1 at higher concentrations increased IL-8 production of HMC3 on its own, AME-1 notably potentiated HMC3 production of IL-8 in response to poly(I:C). AME-1 altered expression of toll-like receptor 3 (TLR3) mRNA but not surface protein by HMC3. AME-1 also did not significantly alter expression of retinoic acid-inducible gene I (RIG-I) or melanoma differentiation-associated protein 5 (MDA5), both cytosolic sensors of dsRNA. Metabolomics analysis showed that AME-1 contained several metabolites, including the autophagy inducer, trehalose. Like AME-1, trehalose also potentiated HMC3 poly(I:C) mediated production of IL-8. This study suggests that A. muscaria extracts can modify HMC3 inflammatory responses, possibly due to their trehalose content. Recent interest in mushrooms and their components as potential therapies for mental health, along with recent government and health authority approvals, has necessitated a more comprehensive understanding of their effects on the cellular microenvironment of the brain. Amanita muscaria has been ingested as a treatment for a variety of ailments for centuries, most notably those affecting the central nervous system and conditions associated with neuroinflammation. However, the effects of these extracts on neuroinflammatory cells, such as microglia, are unknown. The effect of commercially-sourced A. muscaria extract (AME-1) on human microglial cell line (HMC3) expression of surface receptors such as CD86, CXCR4, CD45, CD125 and TLR4 was determined by flow cytometry. AME-1 upregulated expression of all of these receptors. The effect of AME-1 on HMC3 production of IL-8 and IL-6 was determined and compared to tumor necrosis factor (TNF), polyinosinic-polycytidylic acid [poly(I:C)], substance P and lipopolysaccharide (LPS), all known activators of HMC-3 and primary microglia. HMC3 produced both IL-8 and IL-6 when activated with LPS, TNF and poly(I:C) but not when they were activated with substance P. Although AME-1 at higher concentrations increased IL-8 production of HMC3 on its own, AME-1 notably potentiated HMC3 production of IL-8 in response to poly(I:C). AME-1 altered expression of toll-like receptor 3 (TLR3) mRNA but not surface protein by HMC3. AME-1 also did not significantly alter expression of retinoic acid-inducible gene I (RIG-I) or melanoma differentiation-associated protein 5 (MDA5), both cytosolic sensors of dsRNA. Metabolomics analysis showed that AME-1 contained several metabolites, including the autophagy inducer, trehalose. Like AME-1, trehalose also potentiated HMC3 poly(I:C) mediated production of IL-8. This study suggests that A. muscaria extracts can modify HMC3 inflammatory responses, possibly due to their trehalose content. Recent interest in mushrooms and their components as potential therapies for mental health, along with recent government and health authority approvals, has necessitated a more comprehensive understanding of their effects on the cellular microenvironment of the brain. Amanita muscaria has been ingested as a treatment for a variety of ailments for centuries, most notably those affecting the central nervous system and conditions associated with neuroinflammation. However, the effects of these extracts on neuroinflammatory cells, such as microglia, are unknown. The effect of commercially-sourced A. muscaria extract (AME-1) on human microglial cell line (HMC3) expression of surface receptors such as CD86, CXCR4, CD45, CD125 and TLR4 was determined by flow cytometry. AME-1 upregulated expression of all of these receptors. The effect of AME-1 on HMC3 production of IL-8 and IL-6 was determined and compared to tumor necrosis factor (TNF), polyinosinic-polycytidylic acid [poly(I:C)], substance P and lipopolysaccharide (LPS), all known activators of HMC-3 and primary microglia. HMC3 produced both IL-8 and IL-6 when activated with LPS, TNF and poly(I:C) but not when they were activated with substance P. Although AME-1 at higher concentrations increased IL-8 production of HMC3 on its own, AME-1 notably potentiated HMC3 production of IL-8 in response to poly(I:C). AME-1 altered expression of toll-like receptor 3 (TLR3) mRNA but not surface protein by HMC3. AME-1 also did not significantly alter expression of retinoic acid-inducible gene I (RIG-I) or melanoma differentiation-associated protein 5 (MDA5), both cytosolic sensors of dsRNA. Metabolomics analysis showed that AME-1 contained several metabolites, including the autophagy inducer, trehalose. Like AME-1, trehalose also potentiated HMC3 poly(I:C) mediated production of IL-8. This study suggests that A. muscaria extracts can modify HMC3 inflammatory responses, possibly due to their trehalose content. Recent interest in mushrooms and their components as potential therapies for mental health, along with recent government and health authority approvals, has necessitated a more comprehensive understanding of their effects on the cellular microenvironment of the brain. has been ingested as a treatment for a variety of ailments for centuries, most notably those affecting the central nervous system and conditions associated with neuroinflammation. However, the effects of these extracts on neuroinflammatory cells, such as microglia, are unknown. The effect of commercially-sourced extract (AME-1) on human microglial cell line (HMC3) expression of surface receptors such as CD86, CXCR4, CD45, CD125 and TLR4 was determined by flow cytometry. AME-1 upregulated expression of all of these receptors. The effect of AME-1 on HMC3 production of IL-8 and IL-6 was determined and compared to tumor necrosis factor (TNF), polyinosinic-polycytidylic acid [poly(I:C)], substance P and lipopolysaccharide (LPS), all known activators of HMC-3 and primary microglia. HMC3 produced both IL-8 and IL-6 when activated with LPS, TNF and poly(I:C) but not when they were activated with substance P. Although AME-1 at higher concentrations increased IL-8 production of HMC3 on its own, AME-1 notably potentiated HMC3 production of IL-8 in response to poly(I:C). AME-1 altered expression of toll-like receptor 3 (TLR3) mRNA but not surface protein by HMC3. AME-1 also did not significantly alter expression of retinoic acid-inducible gene I (RIG-I) or melanoma differentiation-associated protein 5 (MDA5), both cytosolic sensors of dsRNA. Metabolomics analysis showed that AME-1 contained several metabolites, including the autophagy inducer, trehalose. Like AME-1, trehalose also potentiated HMC3 poly(I:C) mediated production of IL-8. This study suggests that extracts can modify HMC3 inflammatory responses, possibly due to their trehalose content. |
| Author | Pehar, Marcus Kulka, Marianna Wagner, Ashley Yan, Zhimin |
| AuthorAffiliation | 1 Nanotechnology Research Centre , National Research Council Canada , Edmonton , AB , Canada 2 Neuroscience and Mental Health Institute , University of Alberta , Edmonton , AB , Canada |
| AuthorAffiliation_xml | – name: 1 Nanotechnology Research Centre , National Research Council Canada , Edmonton , AB , Canada – name: 2 Neuroscience and Mental Health Institute , University of Alberta , Edmonton , AB , Canada |
| Author_xml | – sequence: 1 fullname: Wagner, Ashley – sequence: 2 fullname: Pehar, Marcus – sequence: 3 fullname: Yan, Zhimin – sequence: 4 fullname: Kulka, Marianna |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/37124206$$D View this record in MEDLINE/PubMed |
| BookMark | eNp9Uktv1DAQjlARLaV_gAPKkcsufsVxTmhV8ahUgYTgbI1fuy6JHRynYv89zu5StRzwwfbY38OemZfVWYjBVtVrjNaUiu6dG3eQ1gQRusYYEcabZ9UF5pyuOoHJ2aP9eXU1TXeoDNp1lLMX1TltMWEE8YsqbgYIPkM9zJOG5KG2v3MCnesxZhuyh2ynekzRzDr7GOrolsgH18MwQI5pX-t9jj99KDi1r8307ctmVQT8faGaejcXg3rwOsVt7-FV9dxBP9mr03pZ_fj44fv159Xt108315vblW44ySvOGtIKJwR1FDoNjRGEO4cE0a1rkQKOhGIKtGBEOMKJobi1ClHFbEOB0cvq5qhrItzJMfkB0l5G8PJwENNWQspe91YS3THXNi0RiLNiohjujKWs6ZTrgDZF6_1Ra5zVYI0uaUnQPxF9ehP8Tm7jvcQI06LZFoW3J4UUf812ynLwk7Z9D8HGeZLFWhDMBF_M3jw2e3D5W7ICIEdAyeg0JeseIBjJpTXkoTXk0hry1BqFJP4h6VL0paDlwb7_P9UcqSFpDQEMPPm59lP20i-LLAipDxMcz8MIJWpLZphAVDZOYcmoE1K5ppHC2Ba4YAYbRf8AekLl2Q |
| CitedBy_id | crossref_primary_10_3390_neuroglia4030012 crossref_primary_10_1038_s41598_024_75982_1 crossref_primary_10_3390_molecules28196824 crossref_primary_10_1111_bpa_13240 |
| Cites_doi | 10.1021/acschemneuro.7b00177 10.1016/s0166-4328(03)00096-2 10.1186/1742-2094-9-268 10.1159/000235563 10.1038/s41593-018-0290-2 10.3389/fneur.2022.890217 10.1371/journal.pone.0273920 10.4997/JRCPE.2018.119 10.1002/glia.22883 10.3390/ijms22168800 10.3390/v15010044 10.1016/j.neulet.2004.01.082 10.3389/fimmu.2019.01586 10.1016/j.cpnec.2021.100048 10.1016/j.virusres.2020.198110 10.1186/s12868-023-00777-5 10.3389/fphar.2023.971136 10.1016/j.bbadis.2018.10.013 10.1186/s13195-023-01186-w 10.1523/JNEUROSCI.2400-10.2010 10.1007/s00441-018-2922-y 10.1038/mp.2016.90 10.1186/s12974-021-02227-7 10.1016/0304-3940(94)11792-h 10.1016/j.expneurol.2018.07.016 10.1007/s10571-022-01284-7 10.1186/s12974-020-01842-0 10.1016/j.jneumeth.2012.05.025 10.4049/jimmunol.175.7.4320 10.1016/j.neuro.2022.08.005 10.1093/intimm/dxaa073 10.1186/s12974-018-1288-0 10.1016/j.bbi.2022.07.158 10.1186/s12950-017-0161-8 10.7150/thno.72713 10.1186/s12974-017-1012-5 10.1016/j.bbr.2013.10.044 10.1038/s41598-021-89777-1 10.1038/s41598-021-00465-6 10.1186/s12974-015-0310-z 10.1007/s12035-021-02694-2 10.1128/JVI.73.1.205-213.1999 10.1002/eji.201746989 10.1186/s12977-020-00544-y 10.1016/j.ejphar.2012.03.025 10.1038/s41598-022-21169-5 10.33140/jcei.08.01.01 10.1017/S0953756203007305 10.1007/s12028-022-01638-5 10.1038/s41598-021-85702-8 10.1007/s12035-010-8106-8 10.1371/journal.pone.0125419 10.1111/jnc.15788 10.3389/fncel.2018.00329 10.1007/s12640-014-9487-7 10.1016/j.anai.2021.08.004 |
| ContentType | Journal Article |
| Copyright | Creative Commons, Attribution 4.0 International (CC BY 4.0) (https://creativecommons.org/licenses/by/4.0/) Creative Commons, Attribution 4.0 International (CC BY 4.0) (https://creativecommons.org/licenses/by/4.0/deed.fr) Copyright © 2023 Wagner, Pehar, Yan and Kulka. Copyright © 2023 Wagner, Pehar, Yan and Kulka. 2023 Wagner, Pehar, Yan and Kulka |
| Copyright_xml | – notice: Creative Commons, Attribution 4.0 International (CC BY 4.0) (https://creativecommons.org/licenses/by/4.0/) Creative Commons, Attribution 4.0 International (CC BY 4.0) (https://creativecommons.org/licenses/by/4.0/deed.fr) – notice: Copyright © 2023 Wagner, Pehar, Yan and Kulka. – notice: Copyright © 2023 Wagner, Pehar, Yan and Kulka. 2023 Wagner, Pehar, Yan and Kulka |
| DBID | -LJ GXV AAYXX CITATION NPM 7X8 5PM DOA |
| DOI | 10.3389/fphar.2023.1102465 |
| DatabaseName | National Research Council Canada Archive CISTI Source CrossRef PubMed MEDLINE - Academic PubMed Central (Full Participant titles) Directory of Open Access Journals - May need to register for free articles |
| DatabaseTitle | CrossRef PubMed MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic PubMed CrossRef |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Sciences Pharmacy, Therapeutics, & Pharmacology |
| DocumentTitleAlternate | Wagner et al |
| EISSN | 1663-9812 |
| ExternalDocumentID | oai_doaj_org_article_2c94f757280646ffb419de3459bf9a35 PMC10130647 37124206 10_3389_fphar_2023_1102465 oai_cisti_icist_nrc_cnrc_ca_cistinparc_7edc4803_5fb1_43f8_bf55_8de7a684d1db |
| Genre | Journal Article |
| GrantInformation_xml | – fundername: ; |
| GroupedDBID | -LJ 53G 5VS 9T4 AAFWJ AAKDD ACGFO ACGFS ADBBV ADRAZ AENEX AFPKN ALMA_UNASSIGNED_HOLDINGS AOIJS BAWUL BCNDV DIK EMOBN GROUPED_DOAJ GX1 GXV HYE KQ8 M48 M~E O5R O5S OK1 P2P PGMZT RNS RPM AAYXX ACXDI CITATION IAO IEA IHR IHW IPNFZ NPM RIG 7X8 5PM |
| ID | FETCH-LOGICAL-c562t-645278f883f3a9ca5d826ff082c7f70ba608b4bac8428f262d317eb03b4e53a43 |
| IEDL.DBID | M48 |
| ISSN | 1663-9812 |
| IngestDate | Wed Aug 27 01:26:06 EDT 2025 Thu Aug 21 18:38:16 EDT 2025 Thu Jul 10 21:43:16 EDT 2025 Thu Jan 02 22:52:53 EST 2025 Thu Apr 24 23:02:47 EDT 2025 Tue Jul 01 02:53:03 EDT 2025 Fri Aug 22 15:34:47 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Keywords | HMC3 cells HMC3 inflammation cytokines toll-like receptor trehalose microglia |
| Language | English |
| License | Copyright © 2023 Wagner, Pehar, Yan and Kulka. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c562t-645278f883f3a9ca5d826ff082c7f70ba608b4bac8428f262d317eb03b4e53a43 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 Edited by: Jacob Raber, Oregon Health and Science University, United States Reviewed by: Kaushik Sharma, Purdue University, United States This article was submitted to Neuropharmacology, a section of the journal Frontiers in Pharmacology Marta Valenza, Sapienza University of Rome, Italy |
| OpenAccessLink | http://journals.scholarsportal.info/openUrl.xqy?doi=10.3389/fphar.2023.1102465 |
| PMID | 37124206 |
| PQID | 2808214865 |
| PQPubID | 23479 |
| ParticipantIDs | doaj_primary_oai_doaj_org_article_2c94f757280646ffb419de3459bf9a35 pubmedcentral_primary_oai_pubmedcentral_nih_gov_10130647 proquest_miscellaneous_2808214865 pubmed_primary_37124206 crossref_primary_10_3389_fphar_2023_1102465 crossref_citationtrail_10_3389_fphar_2023_1102465 nrccanada_primary_oai_cisti_icist_nrc_cnrc_ca_cistinparc_7edc4803_5fb1_43f8_bf55_8de7a684d1db |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2023-04-12 |
| PublicationDateYYYYMMDD | 2023-04-12 |
| PublicationDate_xml | – month: 04 year: 2023 text: 2023-04-12 day: 12 |
| PublicationDecade | 2020 |
| PublicationPlace | Switzerland |
| PublicationPlace_xml | – name: Switzerland |
| PublicationTitle | Frontiers in pharmacology |
| PublicationTitleAlternate | Front Pharmacol |
| PublicationYear | 2023 |
| Publisher | Frontiers Media Frontiers Media S.A |
| Publisher_xml | – name: Frontiers Media – name: Frontiers Media S.A |
| References | Pišlar (B37) 2022; 59 Li (B25) 2009; 1 Townsend (B44) 2004; 362 Wang (B52) 2021; 11 Fiebich (B14) 2018; 12 Khaboushan (B20) 2022; 17 Wang (B48) 2022; 12 dello Russo (B11) 2018; 15 Albright (B3) 1999; 73 Burmeister (B7) 2017; 14 Tamura (B43) 2022; 13 Lawrence (B22) 2022; 128 Lu (B27) 2021; 6 He (B16) 2021; 11 Mitterreiter (B32) 2017; 47 Zieglgänsberger (B56) 2019; 375 Onizawa (B34) 2021; 33 Zhou (B55) 2023; 24 Brisse (B6) 2019; 10 Parajuli (B36) 2012; 9 Pahan (B35) 2023; 8 Deleidi (B10) 2010; 30 Abdelaziz (B1) 2022; 92 Scott (B40) 2022 Lee (B24) 2018; 48 Wang (B53) 2017; 14 Michelot (B31) 2003; 107 Wang (B50) 2023; 14 Martano (B29) 2017; 8 Sil (B42) 2022; 15 Crill (B8) 2015; 63 Li (B26) 2022; 12 Wang (B51) 2021; 11 Trépanier (B45) 2016; 21 Janabi (B18) 1995; 195 Wang (B49) 2023; 15 Rai (B38) 2020; 17 Böttcher (B5) 2019; 22 Jha (B19) 2023 Angel-Ambrocio (B4) 2020; 288 Zhang (B54) 2014; 262 Sienkiewicz-Jarosz (B41) 2003; 145 Tumati (B46) 2012; 684 Ni (B33) 2021; 18 de Koning (B9) 2022; 106 Massenzio (B30) 2018; 1864 Jack (B17) 2005; 175 Lue (B28) 2010; 41 Walker (B47) 2018; 309 Kim (B21) 2021; 22 Dong (B12) 2020; 17 Rajalakshmy (B39) 2015; 10 He (B15) 2014; 26 Lee (B23) 2015; 12 Etemad (B13) 2012; 209 Ahn (B2) 2022 |
| References_xml | – volume: 8 start-page: 1865 year: 2017 ident: B29 article-title: Biosynthesis of astrocytic trehalose regulates neuronal arborization in hippocampal neurons publication-title: ACS Chem. Neurosci. doi: 10.1021/acschemneuro.7b00177 – volume: 145 start-page: 17 year: 2003 ident: B41 article-title: Rat behavior in two models of anxiety and brain [3H]muscimol binding: Pharmacological, correlation, and multifactor analysis publication-title: Behav. Brain Res. doi: 10.1016/s0166-4328(03)00096-2 – volume: 9 start-page: 268 year: 2012 ident: B36 article-title: GM-CSF increases LPS-induced production of proinflammatory mediators via upregulation of TLR4 and CD14 in murine microglia publication-title: J. Neuroinflammation doi: 10.1186/1742-2094-9-268 – volume: 1 start-page: 570 year: 2009 ident: B25 article-title: NOX4 expression in human microglia leads to constitutive generation of reactive oxygen species and to constitutive il-6 expression publication-title: J. Innate Immun. doi: 10.1159/000235563 – volume: 22 start-page: 78 year: 2019 ident: B5 article-title: Human microglia regional heterogeneity and phenotypes determined by multiplexed single-cell mass cytometry publication-title: Nat. Neurosci. doi: 10.1038/s41593-018-0290-2 – volume: 13 start-page: 890217 year: 2022 ident: B43 article-title: Animal models for neuroinflammation and potential treatment methods publication-title: Front. Neurology doi: 10.3389/fneur.2022.890217 – volume: 17 start-page: e0273920 year: 2022 ident: B20 article-title: Cytokines and chemokines profile in encephalitis patients: A meta-analysis publication-title: PLoS One doi: 10.1371/journal.pone.0273920 – volume: 48 start-page: 85 year: 2018 ident: B24 article-title: Amanita muscaria (fly agaric): From a shamanistic hallucinogen to the search for acetylcholine publication-title: J. R. Coll. Physicians Edinb. doi: 10.4997/JRCPE.2018.119 – volume: 63 start-page: 2168 year: 2015 ident: B8 article-title: RIG-I is required for VSV-induced cytokine production by murine glia and acts in combination with DAI to initiate responses to HSV-1 publication-title: Glia doi: 10.1002/glia.22883 – volume: 22 start-page: 8800 year: 2021 ident: B21 article-title: Astrocytes stimulate microglial proliferation and M2 polarization in vitro through crosstalk between astrocytes and microglia publication-title: Int. J. Mol. Sci. doi: 10.3390/ijms22168800 – volume: 15 start-page: 44 year: 2022 ident: B42 article-title: Role of autophagy in HIV-1 and drug abuse-mediated neuroinflammaging publication-title: Viruses doi: 10.3390/v15010044 – volume: 362 start-page: 26 year: 2004 ident: B44 article-title: CD45 isoform RB as a molecular target to oppose lipopolysaccharide-induced microglial activation in mice publication-title: Neurosci. Lett. doi: 10.1016/j.neulet.2004.01.082 – volume: 10 start-page: 1586 year: 2019 ident: B6 article-title: Comparative structure and function analysis of the RIG-I-like receptors: RIG-I and MDA5 publication-title: Front. Immunol. doi: 10.3389/fimmu.2019.01586 – volume: 6 start-page: 100048 year: 2021 ident: B27 article-title: LPS and palmitic acid Co-upregulate microglia activation and neuroinflammatory response publication-title: Compr. Psychoneuroendocrinol doi: 10.1016/j.cpnec.2021.100048 – volume: 288 start-page: 198110 year: 2020 ident: B4 article-title: Microglia HMC3 cells are highly susceptible to Rhinovirus infection publication-title: Virus Res. doi: 10.1016/j.virusres.2020.198110 – volume: 24 start-page: 9 year: 2023 ident: B55 article-title: Activation of autophagy inhibits the activation of NLRP3 inflammasome and alleviates sevoflurane-induced cognitive dysfunction in elderly rats publication-title: BMC Neurosci. doi: 10.1186/s12868-023-00777-5 – volume: 14 start-page: 971136 year: 2023 ident: B50 article-title: Aspirin-triggered Resolvin D1 ameliorates activation of the NLRP3 inflammasome via induction of autophagy in a rat model of neuropathic pain publication-title: Front. Pharmacol. doi: 10.3389/fphar.2023.971136 – volume: 1864 start-page: 3771 year: 2018 ident: B30 article-title: Microglial overexpression of fALS-linked mutant SOD1 induces SOD1 processing impairment, activation and neurotoxicity and is counteracted by the autophagy inducer trehalose publication-title: Biochim. Biophys. Acta Mol. Basis Dis. doi: 10.1016/j.bbadis.2018.10.013 – volume: 15 start-page: 33 year: 2023 ident: B49 article-title: Early activation of Toll-like receptor-3 reduces the pathological progression of Alzheimer’s disease in APP/PS1 mouse publication-title: Alzheimers Res. Ther. doi: 10.1186/s13195-023-01186-w – volume: 30 start-page: 16091 year: 2010 ident: B10 article-title: The toll-like receptor-3 agonist polyinosinic:polycytidylic acid triggers nigrostriatal dopaminergic degeneration publication-title: J. Neurosci. doi: 10.1523/JNEUROSCI.2400-10.2010 – volume: 375 start-page: 227 year: 2019 ident: B56 article-title: Substance P and pain chronicity publication-title: Cell Tissue Res. doi: 10.1007/s00441-018-2922-y – volume: 21 start-page: 1009 year: 2016 ident: B45 article-title: Postmortem evidence of cerebral inflammation in schizophrenia: A systematic review publication-title: Mol. Psychiatry doi: 10.1038/mp.2016.90 – volume: 18 start-page: 176 year: 2021 ident: B33 article-title: Cathepsin H deficiency decreases hypoxia-ischemia-induced hippocampal atrophy in neonatal mice through attenuated TLR3/IFN-β signaling publication-title: J. Neuroinflammation doi: 10.1186/s12974-021-02227-7 – volume: 195 start-page: 105 year: 1995 ident: B18 article-title: Establishment of human microglial cell lines after transfection of primary cultures of embryonic microglial cells with the SV40 large T antigen publication-title: Neurosci. Lett. doi: 10.1016/0304-3940(94)11792-h – volume: 309 start-page: 91 year: 2018 ident: B47 article-title: Increased expression of toll-like receptor 3, an anti-viral signaling molecule, and related genes in Alzheimer’s disease brains publication-title: Exp. Neurol. doi: 10.1016/j.expneurol.2018.07.016 – year: 2022 ident: B2 article-title: Substance P reduces infarct size and mortality after ischemic stroke, possibly through the M2 polarization of microglia/macrophages and neuroprotection in the ischemic rat brain publication-title: Cell Mol. Neurobiol. doi: 10.1007/s10571-022-01284-7 – volume: 17 start-page: 205 year: 2020 ident: B12 article-title: Stress-induced NLRP3 inflammasome activation negatively regulates fear memory in mice publication-title: J. Neuroinflammation doi: 10.1186/s12974-020-01842-0 – volume: 209 start-page: 79 year: 2012 ident: B13 article-title: A novel in vitro human microglia model: Characterization of human monocyte-derived microglia publication-title: J. Neurosci. Methods doi: 10.1016/j.jneumeth.2012.05.025 – volume: 175 start-page: 4320 year: 2005 ident: B17 article-title: TLR signaling tailors innate immune responses in human microglia and astrocytes publication-title: J. Immunol. doi: 10.4049/jimmunol.175.7.4320 – volume: 92 start-page: 110 year: 2022 ident: B1 article-title: SB332235, a CXCR2 antagonist, ameliorates thioacetamide-induced hepatic encephalopathy through modulation of the PI3K/AKT pathways in rats publication-title: Neurotoxicology doi: 10.1016/j.neuro.2022.08.005 – volume: 33 start-page: 225 year: 2021 ident: B34 article-title: Aicardi-Goutières syndrome-like encephalitis in mutant mice with constitutively active MDA5 publication-title: Int. Immunol. doi: 10.1093/intimm/dxaa073 – volume: 15 start-page: 259 year: 2018 ident: B11 article-title: The human microglial HMC3 cell line: Where do we stand? A systematic literature review publication-title: J. Neuroinflammation doi: 10.1186/s12974-018-1288-0 – volume: 106 start-page: 21 year: 2022 ident: B9 article-title: Childhood trauma and LPS-stimulated inflammation in adulthood: Results from The Netherlands study of depression and anxiety publication-title: Brain Behav. Immun. doi: 10.1016/j.bbi.2022.07.158 – volume: 14 start-page: 13 year: 2017 ident: B53 article-title: Tetramethylpyrazine attenuates periorbital allodynia and neuroinflammation in a model of traumatic brain injury publication-title: J. Inflamm. (United Kingdom) doi: 10.1186/s12950-017-0161-8 – volume: 12 start-page: 5364 year: 2022 ident: B26 article-title: Impairment of autophagy after spinal cord injury potentiates neuroinflammation and motor function deficit in mice publication-title: Theranostics doi: 10.7150/thno.72713 – volume: 14 start-page: 245 year: 2017 ident: B7 article-title: Human microglia and astrocytes constitutively express the neurokinin-1 receptor and functionally respond to substance P publication-title: J. Neuroinflammation doi: 10.1186/s12974-017-1012-5 – volume: 262 start-page: 47 year: 2014 ident: B54 article-title: Temporary inhibition of dorsal or ventral hippocampus by muscimol: Distinct effects on measures of innate anxiety on the elevated plus maze, but similar disruption of contextual fear conditioning publication-title: Behav. Brain Res. doi: 10.1016/j.bbr.2013.10.044 – volume: 11 start-page: 10447 year: 2021 ident: B16 article-title: Mouse primary microglia respond differently to LPS and poly(I:C) in vitro publication-title: Sci. Rep. doi: 10.1038/s41598-021-89777-1 – volume: 11 start-page: 22161 year: 2021 ident: B51 article-title: Cromolyn platform suppresses fibrosis and inflammation, promotes microglial phagocytosis and neurite outgrowth publication-title: Sci. Rep. doi: 10.1038/s41598-021-00465-6 – volume: 12 start-page: 90 year: 2015 ident: B23 article-title: Absence of toll-like receptor 4 (TLR4) extends survival in the hSOD1G93A mouse model of amyotrophic lateral sclerosis publication-title: J. Neuroinflammation doi: 10.1186/s12974-015-0310-z – volume: 59 start-page: 2258 year: 2022 ident: B37 article-title: Cysteine peptidase cathepsin X as a therapeutic target for simultaneous TLR3/4-mediated microglia activation publication-title: Mol. Neurobiol. doi: 10.1007/s12035-021-02694-2 – volume: 73 start-page: 205 year: 1999 ident: B3 article-title: Microglia express CCR5, CXCR4, and CCR3, but of these, CCR5 is the principal coreceptor for human immunodeficiency virus type 1 dementia isolates publication-title: J. Virology doi: 10.1128/JVI.73.1.205-213.1999 – volume: 47 start-page: 1181 year: 2017 ident: B32 article-title: Satellite glial cells in human trigeminal ganglia have a broad expression of functional Toll-like receptors publication-title: Eur. J. Immunol. doi: 10.1002/eji.201746989 – volume: 17 start-page: 35 year: 2020 ident: B38 article-title: Comparative analysis of human microglial models for studies of HIV replication and pathogenesis publication-title: Retrovirology doi: 10.1186/s12977-020-00544-y – volume: 684 start-page: 64 year: 2012 ident: B46 article-title: Tachykinin NK₁ receptor antagonist co-administration attenuates opioid withdrawal-mediated spinal microglia and astrocyte activation publication-title: Eur. J. Pharmacol. doi: 10.1016/j.ejphar.2012.03.025 – volume: 12 start-page: 17915 year: 2022 ident: B48 article-title: MicroRNA-25-5p negatively regulates TXNIP expression and relieves inflammatory responses of brain induced by lipopolysaccharide publication-title: Sci. Rep. doi: 10.1038/s41598-022-21169-5 – volume: 8 start-page: 520 year: 2023 ident: B35 article-title: Cinnamein inhibits the induction of nitric oxide and proinflammatory cytokines in macrophages, microglia and astrocytes publication-title: J. Clin. Exp. Immunol. doi: 10.33140/jcei.08.01.01 – volume: 107 start-page: 107 131 year: 2003 ident: B31 article-title: Amanita muscaria: Chemistry, biology, toxicology, and ethnomycology publication-title: Mycol. Res. doi: 10.1017/S0953756203007305 – year: 2022 ident: B40 article-title: Dexmedetomidine alters the inflammatory profile of rat microglia in vitro publication-title: Neurocrit Care doi: 10.1007/s12028-022-01638-5 – volume: 11 start-page: 8054 year: 2021 ident: B52 article-title: Cromolyn inhibits the secretion of inflammatory cytokines by human microglia (HMC3) publication-title: Sci. Rep. doi: 10.1038/s41598-021-85702-8 – volume: 41 start-page: 115 year: 2010 ident: B28 article-title: Microglia activation and anti-inflammatory regulation in alzheimer’s disease publication-title: Mol. Neurobiol. doi: 10.1007/s12035-010-8106-8 – volume: 10 start-page: e0125419 year: 2015 ident: B39 article-title: Hepatitis C virus NS3 mediated microglial inflammation via TLR2/TLR6 MyD88/NF-κB pathway and toll like receptor ligand treatment furnished immune tolerance publication-title: PLoS One doi: 10.1371/journal.pone.0125419 – year: 2023 ident: B19 article-title: Mechanistic and therapeutic role of NLRP3 inflammasome in the pathogenesis of Alzheimer’s disease publication-title: J. Neurochem. doi: 10.1111/jnc.15788 – volume: 12 start-page: 329 year: 2018 ident: B14 article-title: Role of microglia TLRs in neurodegeneration publication-title: Front. Cell Neurosci. doi: 10.3389/fncel.2018.00329 – volume: 26 start-page: 430 year: 2014 ident: B15 article-title: Trehalose alleviates PC12 neuronal death mediated by lipopolysaccharide-stimulated BV-2 cells via inhibiting nuclear transcription factor NF-κB and AP-1 activation publication-title: Neurotox. Res. doi: 10.1007/s12640-014-9487-7 – volume: 128 start-page: 53 year: 2022 ident: B22 article-title: Interleukin-5 receptor alpha (CD125) expression on human blood and lung neutrophils publication-title: Ann. Allergy, Asthma Immunol. doi: 10.1016/j.anai.2021.08.004 |
| SSID | ssj0000399364 |
| Score | 2.3486404 |
| Snippet | Recent interest in mushrooms and their components as potential therapies for mental health, along with recent government and health authority approvals, has... |
| SourceID | doaj pubmedcentral proquest pubmed crossref nrccanada |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1102465 |
| SubjectTerms | cytokines HMC3 HMC3 cells inflammation microglia Pharmacology toll-like receptor trehalose |
| SummonAdditionalLinks | – databaseName: Directory of Open Access Journals - May need to register for free articles dbid: DOA link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1La9wwEBYll7aH0nfdFyqUXBoT25Il-bgtDaGHEEoCuRShZ7M0a5ust7D_vjOys9ktpb30sst65UWr-ayZjxl9Q8h7h6mkALSkCIXPubJFboTgeSyktJWyrh7VPk_E8Tn_clFfbLX6wpqwUR54XLjDyjU8yhq7KAkuYrS8bHxgvG5sbAxL6qXg87bIVNqD0e8KPp6SARbWHMb-0qD-Z8Ww8r3i6E22PFES7L9P7rbXLlVbmT9FnL8XTm55oqOH5MEUQtLZOPVH5E5oH5P901GDen1Az26PVC0P6D49vVWnXj8h3SwpXhi6WC0dEGVDYXvGo1K07wYsHcLgk_ajECwYjXYRPwEQATuLlJOnbj10P7Bento19cuvJ7Mcz0f8hFs9TV3_6AIL_b5fzc1Tcn70-ezTcT51XcgdxEJDjplOqaJSLDLTOFN7YCAxQqjgZJSFNaJQllvjFDCXWInKQwgSbMEsDzUznD0je23XhheExsqX0gvgLAFoqPO28RUEFNE0daN8EzNS3lhAu0mSHDtjXGmgJmg1naym0Wp6slpGPmzu6UdBjr-O_oiG3YxEMe10ASCmJ4jpf0EsI982sNj5JYfbsJ7jm4YR2qUXM15ve9iptASwcFUwXUdbas6i0jbWtVY-SCMU96W3GXl3AzUNDzdmbEwbutVSw4xUBYQV_8jzEXqbCTAJoVlViIyoHVDuzHD3m3Z-mQTES0xXCy5f_o_VeUXu4YrnSf_yNdkbrlfhDQRqg32bnslfqUdABg priority: 102 providerName: Directory of Open Access Journals |
| Title | Amanita muscaria extract potentiates production of proinflammatory cytokines by dsRNA-activated human microglia |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/37124206 https://www.proquest.com/docview/2808214865 https://pubmed.ncbi.nlm.nih.gov/PMC10130647 https://doaj.org/article/2c94f757280646ffb419de3459bf9a35 |
| Volume | 14 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LbxMxELZKOQAHxJvwqIyEeqEL-_Da3gNCAVFVSFQVaqRekOVnG5HsLnkg8u-Z8W5SggonLomysVdez9jzzc74G0JeWgwleXBLUp-6hEmTJppzloRUCJNLY8uO7fOYH43Yp7PybIesyx31Ezi_0rXDelKj2eT1z--rd7Dg36LHCfb2TWgvNFJ75gUmteeMl9fIdbBMAisafO7hftyZ0Rpz1p2d-UvXLfsUafxvkRv1zMYcLH0VDv0znfI3-3R4h9zugSUddppwl-z4-h7ZP-mYqVcH9PTyoNX8gO7Tk0vO6tV90gwjD4am0-XcgvusKWzaeICKts0CE4oQktK2o4cFUdIm4C-YMNCoaYzUU7taNN8wi56aFXXzL8fDBE9N_ICujsZagHSK6X_nk7F-QEaHH08_HCV9LYbEAkJaJBj_FDJIWYRCV1aXDvySEABAWBFEajRPpWFGWwn-TMh57gCYeJMWhvmy0Kx4SHbrpvaPCQ25y4Tj4Ml4cE6tM5XLAWYEXZWVdFUYkGwtAWV7onKslzFR4LCg1FSUmkKpqV5qA_Jq06ftaDr-2fo9CnbTEim244Vmdq76FatyW7EgSizfxRk8qmFZ5XzBysqEShdwk68btdi6k8XNWY3xS0ELZeOH7q7XLexfSoCyMJkWqgwmU6wIUplQlko6LzSXzGXODMiLtaopWPIYx9G1b5ZzBSOSObix-CCPOtXbDKAQANjylA-I3FLKrRFu_1OPLyKteIZBbM7Ek_8xO0_JTZzxJLJiPiO7i9nSPwf4tjB78bXHXlyZvwAMSUm8 |
| linkProvider | Scholars Portal |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Amanita+muscaria+extract+potentiates+production+of+proinflammatory+cytokines+by+dsRNA-activated+human+microglia&rft.jtitle=Frontiers+in+pharmacology&rft.au=Ashley+Wagner&rft.au=Marcus+Pehar&rft.au=Marcus+Pehar&rft.au=Zhimin+Yan&rft.date=2023-04-12&rft.pub=Frontiers+Media+S.A&rft.eissn=1663-9812&rft.volume=14&rft_id=info:doi/10.3389%2Ffphar.2023.1102465&rft.externalDBID=DOA&rft.externalDocID=oai_doaj_org_article_2c94f757280646ffb419de3459bf9a35 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1663-9812&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1663-9812&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1663-9812&client=summon |